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ABSTRACT
Objective: Aim of this study is to determine the association between tardive dyskinesia (TD) and quality of life (QOL).
Methods: Seventy-one stable schizophrenia patients with TD attending psychiatric clinic at Hospital Raja Perempuan
Zainab H (HRPZ II) or Hospital Universiti Sains Malaysia (HUSM) between January to November 2011 were assessed by a sin-
gle rater. TD, QOL and psychopathology were assessed using Abnormal Involuntary Movement Scale (AIMS), Quality of Life
Scale (QLS) and Positive and Negative Symptom Scale (PANSS) respectively. The main outcome in this study was QLS total
score. Descriptive analysis, simple linear regression and multiple linear regressions were appropriately used in data analysis.
Results: Majority of subjects were unemployed (73.2%), single (63.4%), Malay (98.6%) male (70.4%), and on typical
antipsychotics before onset of TD (95.8%). The mean duration of illness and mean duration on treatment were 22 (SD 9.9) and
21.8 (SD 10.1) respectively. Mild, moderate and severe TD was experienced by 54.9, 32.4 and 12.7 % of subjects in that order.
The mean QLS total score was 52.11 (SD 26.7) with the majority of subjects (76.1%) scored lower than mid score indicating low
level of QOL. Employment status, marital status, PANSS negative symptoms and severity of TD were negatively associated with
QOL.
Conclusions: These fíndiugs convey important message to the health care providers to recognize QOL was significantly and
negatively associated with severity of TD and negative symptoms. Further, low QOL was also associated with the subjects being
single, unemployed or partially employed.
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INTRODUCTION
Antipsychotics are an important component of schizophrenia
treatment. However, prolonged use of antipsychotics is associated
with the occurrence of extrapyramidal side effects (EPS) such as
parkinsonism, dystonia, akathisia, and tardive dyskinesia (TD) repre-
sents one of the most serious complications of treatment with
antipsychotics. TD is characterized by involuntary movements, typi-
cally of the mouth, lips, and tongue, but may involve any muscle in
the body. The longer the patients take antipsychotics, the more likely
they arc to experience TD. About 10-20% of patients who are treated
for more than one year have TD and about 15-20% of long-term hos-
pital patients have TD (Sadock and Sadock, 2003). The physical dis-
abilities due to TD can affect patient's Quality Of Life (QOL).
QOL is now recognized as an important health outcome measure.
QOL is generally thought to include life satisfaction, social function-
ing, daily living activities, and physical health, and it has been recog-
nized as an important indicator of how well patients with schizophre-
nia can function. To date, there is only a few studies examined the
association between TD and reduced QOL. A study involving 60
patients examined the influence of socio-demographic, clinical and
treatment factors on QOL of patients with schizophrenia". That study
found that TD was associated with a poorer QOL. However, given
the relatively small sample of patients with TD (n = 15) in that study,
the conclusions must be interpreted with caution. Another study com-
paring the QOL of schizophrenia patients treated with clozapine or
first generation antipsychotics found that lack of EPS predicted
QOL-'. Data from clozapine-haloperidol study for patients with treat-
ment resistant schizophrenia showed a small but progressive decline
in QOL with more severe TD". Another study comparing olanzapine
and haloperidol for patients with non-treatment resistant schizophre-
nia also showed significantly lower QOL scores with TD'".
Hence, this study aims to determine the QOL of schizophrenia
patients with TD using a newly developed and validated Malays ver-
sion quality of life score (QSL)". This study also aims to find an
association between TD and patients' socio-demographic and clinical
variables.
METHODOLOGY
Study sample
The study protocol was approved by the Research and Ethics
Committee, School of Medical Science, Universiti Sains Malaysia
and Ministry of Health. A written consent was obtained from the
patient before the researcher administered the questionnaires. The
subjects were 71 clinically stable, aged 18 to 65, schizophrenia out-
patients with TD conveniently recruited from HUSM or HRPZ II dur-
ing the study period January to November 2011. All the patients were
cooperative and understand the Malay language. Patients with mental
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Table 1. Socio-demographic characteristics of the subjects
(n = 71)
Table 2. Clinical characteristics of the subjects (n = 71)
Frequency (%) Median (IQR)
Frequency ( Median (IQR) Mean (SD)
Age (year)
18-35
36-45
46-55
56-65
Gender
Male
Female
Race
Malay
Chinese
Educational level
Never schooling
Primary
Secondary
Tertiary
Marital status
Single
Married
Divorced/widow
Employment status
Unemployed
Full time Employment
Part time Employment
Household income
Less than RM 500
RM 501-RM 1,000
RM 1,001-RM 2,000
More than RM 2,000
Living arrangement
Alone
With family
With friend/maid
12(16.9)
17 (23.9)
18(25.4)
24 (33.8)
50 (70.4)
21 (29.6)
70 (98.6)
1 (1.4)
2(2.8)
26 (36.6)
40 (56.3)
3 (4.2)
45 (63.4)
9(12.7)
17 (23.9)
52 (73.2)
12(16.9)
7 (9.9)
23 (32.4)
28 (39.4)
14(19.7)
6 (8.5)
8(11.3)
61 (85.9)
2(2.8)
49 (20)
retardation or substance abuse were excluded from the study.
Assessments
The socio-demographic and clinical variables questionnaires
comprised of participants' age, gender, ethnicity, marital status,
employment status, educational level, family income, living arrange-
ment, age at first treatment, number of hospitalization, duration of
outpatient treatment after last hospitalization, overall duration of ill-
ness, type of antipsychotic prior to onset of abnormal movement and
current antipsychotic, duration on previous and current antipsychotic
and overall duration on treatment were administered to the patients.
Patients' qualities of life were assessed using the Quality of Life
Scale (QLS) Malay version". QLS is a semi-structtired interview in
which a trained clinician rates the patient's quality of life on the basis
of the patient's self-report and the clinician's professional judgment
about the patient's functioning and life circumstances". Each of the
scale's 21 items is rated from 0 to 6, and the scale provides descrip-
tive anchors for every other point. High scores (scores of 5 or 6) for a
particular item reflects normal or unimpaired functioning compared
to local norms.
Abnormal Involuntary Movement Scale (AIMS) was used to
establish the presence and severity of involuntary movements in
patients with schizophrenia". AIMS consists of rating the severity of
movement in three main anatomic areas (facial/oral, extremities, and
trunk), based on a five-point scale (0 = none, 4 = severe). The scale
provides a total score (items 1 through 7) or item 8 can be used in
isolation as an indication of overall severity of symptoms.
Patients' psychopathology was scored using the Positive and
Negative Symptom Severity of Schizophrenia (PANSS) based upon
information relating to the past week". There are 7 items for PANSS
positive syndrome and PANSS negative syndrome. For PANSS gen-
eral psychopathology, there are 16 items. In the study analysis, total
Age at first treatment
(year)
Overall duration of
treatment (year)
Duration on same
medication prior
onset of TD (year)
Duration on current
medication after onset
of TD (year)
Overall duration of
illness (year)
Duration of outpatient
treatment after last
hospitalization (year)
Less than 6 months
7 months to 1 year
1 to 3 years
More than 3 years
Number of
hospitalization
Type of
pharmacotherapy
before onset of TD
Typical
antipsychotic
Atypical
antipsychotic
Type of
pharmacotherapy after
onset of TD
Typical
antipsychotic
Atypical
antipsychotic
Both type
Psychiatric symptoms
severity
PANSS total score
PANSS positive
PANSS negative
PANSS general
psychopathology
Severity of TD
(AIMS score)
Mild
Moderate
Severe
QLS score (total)
Below midpoint
20 (28.2)
9(12.7)
10(14.1)
32 (45.1)
68 (95.8)
3 (4.2)
30 (42.3)
40 (56.3)
1 (1.4)
40 (56.3)
22(31)
9 (12.7)
54(76.1)
24.8 (5.9)
21.8(10.1)
8.2 (5.7)
1.7(1.4)
22 (9.9)
3 (5.4)
7(9)
49.8(13.5)
10.2 (3.2)
15.0 (5.6)
24.6 (6.0)
8.6 (4.8)
52.11
(26.7)
score for all three subscales were calculated. Then, the total score for
each subscale was also calculated. Finally, the case record was
reviewed by researcher to acquire detail information regarding cur-
rent type of pharmacotherapy, either monotherapy with typical
antipsychotic or atypical antipsyehotic or polytherapy with combina-
tion of atypical, typical or depot antipsychotic.
Statistical Analysis
Data entry and statistical analysis were conducted using
Predictive Analytics Software (PASW) Statistics version 18.0.
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Table 3. Simple linear regression analysis of socio-demographic
and clinical factors with level of quality of life
Variable Simple Linear Regression"
b' (95% CI) t stat P-value
Table 4. Adjusted factors related to the level of quality of life
among schizophrenia patient with TD
Variable
Age (year)
Gender
Education
Never schooling vs. Tertiary
Primary vs. Tertiary
Secondary vs. Tertiary
Marital Status
Single vs. Married
Divorced/widow vs. Married
Employment Status
Part time vs. full time
Unemployed vs. full time
Household Income
< RM 500 vs. > RM 2,000
RM 501-1,000 vs. >
RM 2,000
RM 1,001-2,000 vs. >
RM 2,000
Living arrangement
With family vs. Alone
With friend/maid vs. Alone
Age at first treatment
Overall duration of treatment
(year)
Duration on same medication
prior to onset of TD (year)
Duration on current medication
after onset of TD (year)
Overall duration of illness
(year)
Duration of out-patient
treatment after last
hospitalization (year)
Number of hospitalization
Type of pharmacotherapy
before onset of TD
Type of pharmacotherapy after
onset of TD
Atypical vs. Typical
antipsychotic
Both type vs. Typical
antipsychotic
Psychiatric symptoms severity
PANSS positive
PANSS negative
PANSS general
psychopathology
Severity of TD
AIMS total score
0.41 (-0.17,0.98) 1.42 0.16
-6.67 (-20.52,7.18) -0.96 0.34
-45.17 (-93.31,1.98) -1.91 0.060
-42.78 (-74.27,-11.29) -2.71 0.008'
-38.37 (-69.28, -7.45) -2.48 0.016'
39.42 (-56.67,-22.18) -4.56 < 0.001"
-29.75 (-49.22,-10.28) -3.05 0.003'
-37.75 (-51.40,-24.11) -5.52 < 0.001'
-59.96 (-69.15,-50.77) -13.02 < 0.001'
-46.04 (-67.71,-24.38) -4.24 < 0.001'
-24.39 (-45.65,-3.13) -2.29 0.025'
-27.14 (-50.20,-4.08) -2.35 0.022'
-21.84 (-41.02,-2.67) -2.27 0.026'
13.50 (-26.81,53.81) 0.668 0.506
1.01 (-0.05,2.06) -1.90 0.061
0.13 (-0.50,0.76)
0.58 (-0.53,1.68)
3.47 (-1.02,7.96)
0.12 (-0.52,0.77)
2.20(1.10,3.30)
0.42 0.678
1.04 0.302
1.54 0.128
0.39 0.699
3.99 < 0.001'
-1.74 (-2.69,-0.78) -3.63 0.001'
-16.82(-17.87,12.26) -0.37 0.71
-23.08 (-34.84,-11.33) -3.92 < 0.001'
-29.53 (-79.02,19.95) -1.19 0.238
-5.71 (-7.16,-4.25)
-3.67 (-4.40,-2.93)
-3.24 (-3.97,-2.51)
-2.62 (-3.79,-1.45)
-7.83 < 0.001'
-9.94 < 0.001'
-8.88 < 0.001'
-4.48 < 0.001'
°SLR (outcome as QLS total score);
"Crude regression coefficient;
'P-value level of significant < 0.05
Continuous variables were expressed as mean and standard deviation.
Median and inter-quartile range were used when they were not nor-
mally distributed. Categorical variables were expressed as frequen-
cies and percentage. Simple and multiple linear regression analysis
were used to explore the association between socio demographic and
B- (95% CI)
Multiple Linear
Regression
t stat P-value
Employment Status
Part time vs. full time
Unemployed vs. full time
Marital status
Single vs. married
Psychiatric symptoms
severity
PANSS negative
Severity of TD
(AIMS total score)
29.88 (-37.90,-21.86)
40.79 (-46.89,-34.69)
-5.30 (-9.65,-0.95)
-1.66 (-2.01,-1.22)
-0.79 (-1.25,-0.34)
-7.45 < 0.001'
-13.37 <o.oor
-2.44 0.018''
-7.55 < 0.001»
-3.49 0.001'
Severity of TD
Mild
Moderate
Severe
Mean (SD)
62.15 (27.79)
43.68(20.10)
28.11 (7.87)
F-statistic (dO
9.37 (2)
"Adjusted regression coefficient;
'P-value level of significant < 0.05
Table 5. Comparing QLS total score between the three lev-
els of severity of TD by One-way ANOVA
P-value
< 0.001
clinical factors with the level of quality of life. Then, ANOVA and
post hoc test were used to compare the mean differences between
QLS total score (level of QOL) and three levels of the severity of TD.
RESULTS
A total of 79 patients fulfilled the inclusion and exclusion criteria
and invited to participate in the study from January to November
2011. However, 8 patients refused to participate because they were in
a hurry. Thus, a total of 71 schizophrenia patients with neuroleptic-
induced TD participated in this study. The socio-demographic and
clinical characteristics of the study participants are summarised in
table 1 and table 2 respectively. Majority of subjects were unem-
ployed, single, Malay, males, educated up to secondary level and liv-
ing with the family with household income less than RM 1,000.
Most subjects experienced mild TD, had been on out-patient
treatment for more than 3 years, received typical before and atypical
antipsychotics after the onset of TD as summarized in table 2.
However, majority of subjects (76.1%) scored below the midpoint
reflecting overall poor quality of life among study participants.
Each of the independent socio-demographic and clinical variables
were analyzed using simple linear regression analysis (SLR) to deter-
mine any association between socio-demographic and clinical vari-
ables, with the level of quality of life measured by QLS. Race was
not included in the analysis since only 1 out of 71 patients was
Chinese and the other 70 patients were Malays. The results are shown
in tables 3.
The data was further analysed using multiple linear regression
analysis (MLR) to control for confounding effects among the clinical
and statistical significant variables and to determine the significant
associated factors for quality of life. The variables that were found to
be significant by SLR were entered into the MLR. Variables selection
to establish the preliminary main effect model was done using back-
ward linear regression (LR) and forward LR method {p value for
removal is 0.10 and p value for entering is 0.05). The preliminary
main effect model was chosen from backward method and checked
for multi collinearity. There was no multi collinearity among the
variables as evidence by low VIF value (1.19-2.52), small standard
error (compared to each b value) and narrow confidence interval.
The preliminary final model was established and checked further
for assumptions. The model was checked for overall linearity and
equal variance by scatter plot of residuals versus predicted mean
value. The linearity of each numerical independent; namely PANSS
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negative and AIMS total score variable were checked with scatter
plot of residuals versus each independent variables mentioned. The
histogram of the residuals was normally distributed. The model met
all the assumptions. The R^  value is 91%, thus the model could accu-
rately discriminate 91% of the cases. Finally, the final model was
established, and Table 4 showed that employment status, marital sta-
tus (single vs. married), PANSS negative symptoms and AIMS score
for TD are negatively associated with quality of life. In this study, for
every 1 unit increased of AIMS score, the QLS score will decrease by
0.79 (-1.25,-0.34) units. For every 1 unit increase of PANSS negative
symptoms score, the QLS score will decrease by 1.66 (-2.10, -1.22).
One-way ANOVA (table 5) followed by post hoc tests were used
to compare the QLS total score between the three levels of severity of
TD. There were significant differences in QLS total score between
the three levels of severity of TD where severe TD had low QLS total
score. There were significant differences in QLS total score between
mild vs. Moderate (mean 18.47, CI 3.26-33.67) and mild vs. severe
TD (mean 18.47, CI 3.26, 33.67)
DISCUSSION
This study revealed that 12.7% of the patients with schizophrenia
had severe TD and this finding was higher than previously reported
findings. The percentage of schizophrenia patients with severe TD
was earlier reported to be 5.4%" and 3.5%'°'. The inconsistency could
be explained by the differences in participants' characteristics. In ear-
lier study, out of 210 patients screened 37 (17.6%) had TD with only
2 (5.4%) patients had severe TD". However, only 30 (81.1%) of
patients with TD and 144 (83.2%) of patients without TD were cur-
rently receiving neuroleptics. Discontinuation of antipsychotic treat-
ment could have contributed to resolution of TD in some of the
patients.
In another study, 647 Japanese inpatients (361 men and 286
women) with a mean age of 49.8 years, receiving a mean dose of
antipsychotic drugs of 276.8 mg of chlorpromazine equivalent were
assessed for TD"". The overall prevalence of TD was 22.3%. Mild TD
was found in 67.4% of TD patients, moderate TD in 29.2%, and
severe TD in 3.5%. Low percentage of patients with severe TD in
that study was likely due to the use of low dose of antipsychotic in
the study population. It is well established that the dose of antipsy-
chotic drug play a role in development of TD and reducing the dose
of antipsychotic is one of the effective interventions to treat TD'". All
the patients in this study were on antipsychotic treatment and they
were on normal dose for a long period of time. This may explain the
high percentage of severe TD as increased length of antipsychotic
exposure contributed to TD'^ '.
Majority (76.1%) of the patients in this study scored below the
midpoint of QLS total score reflecting poor overall quality of life.
This finding was consistent with previous findings where patients
with schizophrenia have poor quality of life and TD was one of the
contributing factors for their poor quality of life"'*'. In this study,
multiple linear regression analysis was carried out to identify factors
associated with quality of life among schizophrenia patients with TD.
After controlling for potential confounders, employment status, mari-
tal status (single vs. married), PANSS negative symptoms and AIMS
total score variables were negatively associated with QLS total score.
Despite the fact that majority of the patients received secondary
education and suffered only mild psychotic symptoms, majority
(75%) of them were unemployed. Employment allows more social
interactions which can increase quality of life. Previous studies also
reported similar findings as employed patients had significantly high-
er quality of life in terms of physical health, social relations, support
and global QOL score"'". Recent EGOFORS (Employment and its
relationship with functionality and quality of life in patients with
schizophrenia) study reported that those who work/study had lower
symptoms, better functioning and higher levels of QOL"". A study in
China reported that employment status and income significantly con-
tributed to some of the QOL domains'". Another study reported that
total monthly income had significant positive correlation with social
relationship domain and total QOL'".
Our patients with higher PANSS negative symptoms scores were
more likely to have poor quality of life. This finding was in agree-
ment with previous studies™"'. A study involving 50 out-patients
using PANSS and WHO-QOL BREF found that negative subscale
had significant negative correlation with physical and psychological
domains and total QOL'". Another recent study found that severity of
negative symptoms was found to be related to employment status and
those who were unemployed had poor QOL"'. In contrast, a cross-
sectional study of 206 stable out-patients with schizophrenia in simi-
lar setting found the only significant associated factors for subjective
QOL were general psychopathology and depressive symptoms. The
socio-demographic variables, level of function and other clinical fea-
tures were not significantly associated with subjective QOL"'.
This study revealed that severity of TD was negatively associated
with quality of life. When comparing QLS total score and the three
level of severity of TD, there was significant difference in the mean
QLS score between mild and severe TD. There is only one previous
study (involving 60 patients with only 15 patients had TD) examined
the association between TD and quality of life. That study found
modestly lower quality of life in patient with TD". However, the
sample of that study was too small to allow generalization to other
study population. A recent study on the association of treatment-
emergent adverse events with health-related quality of life involving
16091 patients found that TD has negative association with health-
related quality of life"".
There were a few limitations in this study. First, the sample size
was small and the samples were conveniently selected from schizo-
phrenia out-patient thereby limiting the generalization. Similar study
needs to be replicated at different centres. In conclusion, schizophre-
nia patients with TD had low overall quality of life and there were
significant negative associations between quality of life and severity
of TD, negative symptoms as well as subjects being single, unem-
ployed of partially employed. These findings convey important mes-
sage to the health care providers to recognize and treat TD as early as
possible in order to improve their patients' quality of life.
REFERENCES
! ) Browne S, Roe M. Lane A, Gervin M, Morris M, Kinsella A. et al. Quality oí lile in schizophrenia: relation-
ship lo sociodemographie Taclors, symptomatology and lardive dyskinesia. Acta Psychiair Scand 1996; 94(2):
118-24.
2) Strejilevi effects
viih typical antipsycholics. Psychiatry Respredicts quality of lite in outpatients treated with clozapini
2005; 133(2-3): 277-80.
3) Rosenheck R. Cramer J. Xu W. Thomas J. Henderson W, Frisman L. ci al. A comparison of ciozapine and
haloperidol in hospitüli;fcd patients with refractory schizophrenia. Department ol' Veterans Alïairs Cooperative
Study Group on Ciozapine in Refractory Schizophrenia. N EngI J Med 1997; 337(12): 809-15.
4) Ro.scnheck R, Perlick D, Bingham S. Liu-Mares W, Collins J, Warren S, el a!. Effectiveness and cost of olan-
zapinc and haloperidol in the treatment of schizophrenia: a randomized controlled tria!. JAMA 2003; 290(20):
2693-702.
5) Ghazali M, Hamzah MN. Hussin M, Othman Z, Validation of the quality of life scale (QLS) Malay version
among patient.s with schizophrenia. International Medical Journal (in press)
6) Heinrichs DW. Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic
deficit syndrome. Schizophr Bull 1984; 10(3): 388-98.
7) Guy W. ECDEU Assessment manual for psychopharmacoiogy. Department of Health, Education and Welfare
1976:534-537.
8) Kay SR, Opler LA, Fiszhein A. The positive and negative syndrome seale (PANSS) for schizophrenia.
Schizophrenia Bulletin 1987; 13:261-276.
9) Wojcik JD, Gelenberg AJ, LaBrie RA, Micske M. Prevalence of tardive dyskinesia in an outpatient population.
Compr Psychiatry 1980; 21(5): 370-80,
10) Koshino Y. Madokoro S, Ito T, Horie T, Mukai M. Isaki K. A survey of tardive dyskinesia in psychiatric inpa-
tient.s in Japan, Clin Neuropharmacol 1992; 15(1): 34-43.
11) van Harten PN. Tenback DE. Tardive dyskinesia: clinical presentation and treatment. Int Rev Neurobiol 2011 ;
98: 187-210.
12) Miller DD. McEvoy JP. Davis SM, Caroff SN. Saltz BL. Chakos MH, ei al. Clinical correlates of tardive dysk-
inesia in schizophrenia: baseline data from the CA TIE .schizophrenia trial. Schizophr Res 2005; 80(1): 33-43.
13) Rosenheck RA. Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation
antipsychotics. Br J Psychiatry 2007; 191: 238-45.
14) Adrianzen C, Arango-Davita C, Araujo DM, Ruiz I, Walton RJ, et al. Relative association of treatment-emer-
gent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observa-
tional study. Hum Psychopharmacol 2010; 25(6): 439-47.
15) Caron J. Mercier C. Diaz P. Martin A. Socio-demographic and clinical predictors of qtiality of life in patients
with schizophrenia or schizo-affective disorder. Psychiatry Res 2005; 137(3): 203-13.
16) Xiang YT, Wang CY, Wang Y, Chiu HF, Zhao JP, Chen Q, et al. Socio-demographic and clinical determinants
of quality of life in Chinese patients with schizophrenia: a prospective study. Qual Life Res 2010; 19(3): 317-
22.
17) Boyer L. Aghababian V, Richieri R, Loundou A, Padovani R. Simeoni MC, et al. Insighi into illness, neu-
recognition and quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36(2):
271-6.
18) Ücok A, Gorwood P, Karadayi G. Employment and its relationship with functionality and quality of life in
patients with schizophrenia: EGOFQRS Study. Eur Psychiatry 2012; 27(6): 422-5
19) Solanki RK. Singh P, Midha A. Chugh K. Schizophrenia: impact on quality of life. Indian J Psychiatry 2008;
50(3): 181-6.
20) Bankole AQ, Cohen CI, Vahia I. Diwan S, Kehn M, Ramirez FM. Factors affecting quality of life in a multira-
cial sampleof older persons with schizophrenia. Am J Geriatr Psychiatry 2007; 15(12): 1015-23.
21) Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, ei al. Predictors of subjective and objective
quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci 2008; 62(4): 404-11.
22) Kao YC, Liu YP, Chou MK. Cheng TH. Subjective quality of life in patients with chronic schizophrenia: rela-
tionships between psychosocial and clinical characteristics. Compr Psychiatry 2011; 52(2): 171-80.
23) Razali SM, Wahid MA. Quality of life and depressive symptoms in patients with schizophrenia. International
Medical Journal 2012; 19(2): 130-134
Copyright of International Medical Journal is the property of Japan International Cultural
Exchange Foundation and its content may not be copied or emailed to multiple sites or posted
to a listserv without the copyright holder's express written permission. However, users may
print, download, or email articles for individual use.
